Steve Schonfeld’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Steve Schonfeld's VRTX Position: Q2 2026 in Review
Steve Schonfeld opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 2,901 shares worth $1.44M. The stake represents 0.01% of the portfolio and ranks #1260 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in VRTX as recently as Q1 2025.
Steve Schonfeld first reported a position in VRTX in Q1 2016 and has held it in 31 quarters since. The position peaked at $32.9M in Q3 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Steve Schonfeld held 2,901 shares of Vertex Pharmaceuticals worth $1.44M as of Q2 2026.
- Vertex Pharmaceuticals was a new Steve Schonfeld position in Q2 2026.
- Vertex Pharmaceuticals made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1260 holding.
- Steve Schonfeld first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 31 quarters since.
- Steve Schonfeld's Vertex Pharmaceuticals position peaked at $32.9M in Q3 2024.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.